Search the site

Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations

A directed approach to the differential diagnosis of acute rheumatic fever now includes the concept of low-risk versus medium-to-high risk populations

Introduction to the themed issue The health benefits of UV radiation exposure through Vitamin D production or non-Vitamin D pathways

The health benefits of UV radiation exposure through Vitamin D production or non-Vitamin D pathways

Validity and Reliability of the Early Development Instrument in Indonesia

This study finds that the EDI shows moderate validity and reliability in poor communities in Indonesia and highlights some of the difficulties associated with adapting western instruments for non-western cultures and contexts.

Liquor landscapes: Does access to alcohol outlets influence alcohol consumption in young adults?

Longitudinal analyses showed that for each increase in liquor stores over time, alcohol consumption increased

Associations of parental food-choice control and use of food to soothe with adiposity in childhood and adolescence

Higher parental control over food choice was associated with lower adiposity, but use of food to soothe was not associated with adiposity at ages 7 and 15

Advancing Australia's role in climate change and health research

While Australia has established leadership roles in climate science and health research, it must now link these two strengths

Rethinking food and nutrition science: Efective governance for food and nutrition science in Australia

This paper discusses the new nutrition science paradigm, priorities and challenges for the next decade in Australia.

Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

The IHSG recommends that the frequency of detection of a glucose concentration <3.0mmol/L, to be included in clinical trial reports of glucose lowering drugs.

Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder

In this review, we comprehensively evaluate the rationale for oxytocin as a therapeutic, evaluating evidence from various various sources.

Evidence of a reduction over time in the behavioral severity of autistic disorder diagnoses

We examined whether there were changes over time in the qualitative and quantitative phenotype of individuals who received the diagnosis of Autistic Disorder.